USANA HEALTH SCIENCES INC's ticker is USNA and the CUSIP is 90328M107. A total of 157 filers reported holding USANA HEALTH SCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $365,023 | -5.0% | 6,228 | +2.2% | 0.00% | 0.0% |
| Q2 2023 | $384,229 | -0.3% | 6,095 | -0.5% | 0.00% | -33.3% |
| Q1 2023 | $385,388 | +18.8% | 6,127 | +0.5% | 0.00% | +50.0% |
| Q4 2022 | $324,414 | -5.7% | 6,098 | -0.8% | 0.00% | -33.3% |
| Q3 2022 | $344,000 | -22.2% | 6,146 | +0.6% | 0.00% | 0.0% |
| Q2 2022 | $442,000 | -18.8% | 6,107 | -10.8% | 0.00% | 0.0% |
| Q1 2022 | $544,000 | -26.0% | 6,847 | -5.8% | 0.00% | -25.0% |
| Q4 2021 | $735,000 | +2.4% | 7,267 | -6.7% | 0.00% | 0.0% |
| Q3 2021 | $718,000 | -13.9% | 7,788 | -4.4% | 0.00% | +33.3% |
| Q2 2021 | $834,000 | +10.6% | 8,147 | +5.4% | 0.00% | 0.0% |
| Q1 2021 | $754,000 | +25.0% | 7,728 | -1.3% | 0.00% | +50.0% |
| Q4 2020 | $603,000 | +2.0% | 7,827 | -2.4% | 0.00% | -33.3% |
| Q3 2020 | $591,000 | -2.3% | 8,020 | -2.7% | 0.00% | 0.0% |
| Q2 2020 | $605,000 | +21.5% | 8,240 | -4.5% | 0.00% | 0.0% |
| Q1 2020 | $498,000 | -30.0% | 8,626 | -4.7% | 0.00% | 0.0% |
| Q4 2019 | $711,000 | +8.7% | 9,055 | -5.3% | 0.00% | 0.0% |
| Q3 2019 | $654,000 | -18.6% | 9,563 | -5.4% | 0.00% | 0.0% |
| Q2 2019 | $803,000 | +18.4% | 10,113 | +25.2% | 0.00% | 0.0% |
| Q1 2019 | $678,000 | -31.0% | 8,079 | -3.1% | 0.00% | -25.0% |
| Q4 2018 | $982,000 | -3.1% | 8,341 | -0.8% | 0.00% | +33.3% |
| Q3 2018 | $1,013,000 | +6.5% | 8,405 | +1.9% | 0.00% | 0.0% |
| Q2 2018 | $951,000 | +52.6% | 8,248 | +13.8% | 0.00% | +50.0% |
| Q1 2018 | $623,000 | +10.1% | 7,250 | -5.2% | 0.00% | 0.0% |
| Q4 2017 | $566,000 | +26.1% | 7,645 | -1.7% | 0.00% | 0.0% |
| Q3 2017 | $449,000 | -2.6% | 7,778 | +8.1% | 0.00% | 0.0% |
| Q2 2017 | $461,000 | +25.3% | 7,196 | +12.6% | 0.00% | +100.0% |
| Q1 2017 | $368,000 | +0.8% | 6,392 | +7.1% | 0.00% | 0.0% |
| Q4 2016 | $365,000 | -99.9% | 5,970 | +99.4% | 0.00% | -50.0% |
| Q3 2016 | $414,220,000 | +24.3% | 2,994 | +0.1% | 0.00% | +100.0% |
| Q2 2016 | $333,176,000 | -18.5% | 2,990 | -11.2% | 0.00% | -50.0% |
| Q1 2016 | $409,000,000 | -4.9% | 3,367 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $430,000,000 | +95032.7% | 3,367 | -0.2% | 0.00% | 0.0% |
| Q3 2015 | $452,000 | -99.9% | 3,373 | -1.0% | 0.00% | 0.0% |
| Q2 2015 | $465,737,000 | +8.2% | 3,408 | -12.1% | 0.00% | 0.0% |
| Q1 2015 | $430,590,000 | +8.3% | 3,875 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $397,536,000 | +25.0% | 3,875 | -10.2% | 0.00% | +100.0% |
| Q3 2014 | $317,916,000 | -5.7% | 4,316 | +0.0% | 0.00% | 0.0% |
| Q2 2014 | $337,174,000 | +7.0% | 4,315 | +3.2% | 0.00% | 0.0% |
| Q1 2014 | $314,997,000 | +2.1% | 4,181 | +2.4% | 0.00% | 0.0% |
| Q4 2013 | $308,593,000 | -16.0% | 4,083 | -3.6% | 0.00% | -50.0% |
| Q3 2013 | $367,555,000 | +32.2% | 4,235 | +10.3% | 0.00% | 0.0% |
| Q2 2013 | $277,940,000 | – | 3,840 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 34,732 | $3,563,000 | 3.33% |
| Matarin Capital Management, LLC | 28,322 | $2,905,554,000 | 1.28% |
| Capital Impact Advisors, LLC | 21,373 | $2,193,000 | 1.03% |
| USA FINANCIAL FORMULAS | 20,088 | $2,061,000 | 0.71% |
| Camarda Financial Advisors, LLC | 8,951 | $918,000 | 0.58% |
| Invictus RG Pte. Ltd. | 4,862 | $499,000 | 0.54% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 78,238 | $8,026,000 | 0.53% |
| Wolf Group Capital Advisors | 6,696 | $687,000 | 0.50% |
| RQSI Ltd | 3,937 | $404,000 | 0.38% |
| CLARK ESTATES INC/NY | 23,759 | $2,437,000 | 0.36% |